전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,045 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleThe Affiliated Nanjing Drum Tow…Phase 2

Triplizumab (Triplizumab)

Bladder Cancer · Bladder Cancer

#BladderCancer#Antibody#Phase2#monoclonal-antibody#The
Trials 6Status Active
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

anti-CD5 CAR T cells (anti-CD5 CAR T cells)

T-cell Acute Lymphoblastic Leukemia; T-cell Non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 6Status Active
CGTAAVLimited DatastaleMeiraGTx UK II LtdPhase 2

AAV RPE65 (AAV RPE65)

Leber Congenital Amaurosis · Leber Congenital Amaurosis

#LeberCongenitalAmaurosis#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 5Status Active
CGTAAVLimited DatastaleCSL BehringPhase 3

AAV5-hFIXco-Padua (AAV5-hFIXco-Padua)

Hemophilia B · Hemophilia B

#HemophiliaB#CGT#Phase3#cell-gene-therapy#CAR-T+2
Trials 5Status Active
AntibodyLimited DatastaleJuno Therapeutics, Inc., a Bris…Phase 3

Alnuctamab (Alnuctamab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#monoclonal-antibody#Juno
Trials 5Status Discontinued
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

BCMA-CD19 cCAR T cells (BCMA-CD19 cCAR T cells)

Relapsed/Refractory, Systemic Lupus Erythematosus (SLE) · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 5Status Recruiting
AntibodyLimited DatastaleAravive, Inc.Phase 2

Batiraxcept (Batiraxcept)

Clear Cell Renal Cell Carcinoma · Clear Cell Renal Cell Carcinoma

#ClearCellRenalCellCarcinoma#Antibody#Phase2#monoclonal-antibody#Aravive
Trials 5Status Discontinued
AntibodyLimited DatastaleMerck Sharp & Dohme LLCPhase 2

Boserolimab (Boserolimab)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase2#monoclonal-antibody#Carcinoma+2
Trials 5Status Recruiting
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

CART22 cells (CART22 cells)

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 5Status Discontinued
CGTLimited DatastaleGuangdong Ruishun Biotech Co., …Phase 1

CD19-CAR-DNT cells (CD19-CAR-DNT cells)

B-cell Non-Hodgkin's Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 5Status Active
CGTLimited DatastaleGuangzhou Bio-gene Technology C…Phase 1

CDH17 CAR-T (CDH17 CAR-T)

Biliary Tract Cancer; Colorectal Carcinoma · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 5Status Recruiting
CGTAAVLimited DatastaleCSL BehringPhase 3

AAV5-hFIXco-Padua (CSL222, CSL222 (AAV5-hFIXco-Padua))

Hemophilia B · Hemophilia B

#HemophiliaB#CGT#Phase3#cell-gene-therapy#CAR-T+2
Trials 5Status Recruiting
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy (Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 5Status Discontinued
CGTLimited DatastaleAlberta Precision LaboratoriesPhase 1

GCAR1 (GCAR1)

Alveolar Soft Part Sarcoma · Alveolar Soft Part Sarcoma

#AlveolarSoftPartSarcoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 5Status Recruiting
AntibodyLimited DatastaleNovartisPhase 3

Investigational Arm - secukinumab (Investigational Arm - secukinumab)

Plaque Psoriasis; Non-alcoholic Fatty Liver Disease · Plaque Psoriasis

#PlaquePsoriasis#Antibody#Phase3#monoclonal-antibody#Non-alcoholicFattyLiverDisease+1
Trials 5Status Discontinued
CGTLimited DatastaleEssen BiotechPhase 1

Mesothelin-directed CAR-T cells (Mesothelin-directed CAR-T cells)

Solid Tumor, Adult · Solid Tumor, Adult

#SolidTumorAdult#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 5Status Active
CGTLimited DatastaleGuangdong Ruishun Biotech Co., …Phase 1

CD19-CAR-DNT cells (RJMty19, RJMty19 (CD19-CAR-DNT cells))

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 5Status Recruiting
ADCLimited DatastaleSeagen Inc.Phase 2

cBR96-Doxorubicin Immunoconjugate (SGN-15, SGN-15 (cBR96-Doxorubicin Immunoconjugate))

Prostatic Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase2#antibody-drug-conjugate#ProstaticNeoplasms+1
Trials 5Status Active
ADCLimited DatastaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab emtansine [Kadcyla])

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#antibody-drug-conjugate#Roche
Trials 5Status Active
AntibodyLimited DatastaleXencor, Inc.Phase 2

Vudalimab (Vudalimab)

Ovarian Cancer; Clear Cell Carcinoma · Castration-Sensitive Prostate Carcinoma

#Castration-SensitiveProstateCarc#Antibody#Phase2#monoclonal-antibody#OvarianCancer+2
Trials 5Status Discontinued

25 / 103 pages

← PreviousNext →